Carson Wealth (CWM LLC)
NGM

Carson Wealth (CWM LLC)’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6
Closed – – 5073
2024
Q1 		$0 Sell
6
-639
-99% -$948 ﹤0.01% 4858
2023
Q4 		$1K Hold
645
– – ﹤0.01% 4086
2023
Q3 		$1K Sell
645
-1,472
-70% -$3.05K ﹤0.01% 4128
2023
Q2 		$5K Buy
2,117
+844
+66% +$3.01K ﹤0.01% 3489
2023
Q1 		$5K Sell
1,273
-397
-24% -$1.83K ﹤0.01% 3340
2022
Q4 		$8K Buy
1,670
+1,486
+808% +$9.31K ﹤0.01% 2972
2022
Q3 		$2K Buy
+184
New +$2.79K ﹤0.01% 3574

Carson Wealth (CWM LLC)'s NGM Position: Q2 2024 in Review

Carson Wealth (CWM LLC) sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 6 shares.

Carson Wealth (CWM LLC) first reported a position in NGM in Q3 2022 and held it in 7 quarters. The position peaked at $8K in Q4 2022. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

  • Carson Wealth (CWM LLC) reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 6 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024.
  • Carson Wealth (CWM LLC) first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
  • Carson Wealth (CWM LLC)'s NGM Biopharmaceuticals, Inc. Common Stock position peaked at $8K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2024, filed 10 Jul 2024.